Hyperfine, Inc. (HYPR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European markets Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), ...

The Swoop system tackles a critical challenge in health care, limited access to affordable and prompt brain imaging. More than three billion people globally are affected by brain diseases, including ...

GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® ...

Portable MRI maker Hyperfine will go public via a SPAC deal and be listed on the Nasdaq, the company announced Thursday. Guilford-based Hyperfine and brain-monitoring firm Liminal Sciences were ...

GUILFORD, Conn., August 25, 2025--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the ...